Pharmaceutical Industry

By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development. Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools.

The MetaboGen network contains clinicians specialized in various diseases, providing access to patient groups and clinical trial opportunities.